Mergers and acquisitions in digital health bounced back strongly in Q2 after almost grinding to a halt at the start of the year, according to figures released this week.
UK biotech investor Arix Bioscience is looking for a new CEO after Joe Anderson decided to focus on running the investment side of the business and a reshuffle of its board.
Digital health entrepreneurs will get the chance to test and expand their businesses as part of an initiative run by San Francisco-based seed investor and mentor, Launchpad Digital Health.<
IQVIA’s Murray Aitken examines the potential for savings from a new wave of oncology biosimilars – but says payers have to invest in education and incentives to maximise uptake.